Toviwek Borvornwat, Riley Jennifer, Mutter Nicole, Anderson Mark, Webster Lauren, Hallyburton Irene, Gleeson Duangkamol, Read Kevin D, Gleeson M Paul
Department of Biomedical Engineering, School of Engineering, King Mongkut's Institute of Technology Ladkrabang Bangkok 10520 Thailand
Department of Chemistry, Faculty of Science, Kasetsart University Bangkok 0900 Thailand.
RSC Med Chem. 2022 Oct 20;13(12):1587-1604. doi: 10.1039/d2md00218c. eCollection 2022 Dec 14.
The synthesis and evaluation of twenty six new phenylurea substituted 2,4-diamino-pyrimidines against () 3D7 are reported. Compounds were prepared to improve both anti-malarial activity and selectivity of the series previously reported by our group. Additional properties have been determined to assess their potential as anti-malarial leads including; HepG2 cytotoxicity, solubility, permeability, and lipophilicity, as well as stability in human and rat microsomes. We also assess their inhibition profile against a diverse set of 10 human kinases. Molecular docking, cheminformatics and bioinformatics analyses were also undertaken. Compounds 40 demonstrated the best anti-malarial activity at 3D7 (0.09 μM), good selectivity with respect to mammalian cytotoxicity (SI = 54) and low microsomal clearance. Quantitative structure activity relationship (QSAR) analyses point to lipophilicity being a key driver of improved anti-malarial activity. The most active compounds in the series suffered from high lipophilicity, poor aqueous solubility and low permeability. The results provide useful information to guide further chemistry iterations.
报道了二十六个新的苯基脲取代的2,4 - 二氨基嘧啶对恶性疟原虫3D7株的合成与评价。制备这些化合物是为了提高我们小组先前报道的该系列化合物的抗疟活性和选择性。还测定了其他性质以评估它们作为抗疟先导物的潜力,包括:HepG2细胞毒性、溶解度、渗透性、亲脂性,以及在人和大鼠微粒体中的稳定性。我们还评估了它们对多种10种人类激酶的抑制谱。还进行了分子对接、化学信息学和生物信息学分析。化合物40在对3D7株的测试中表现出最佳抗疟活性(0.09 μM),对哺乳动物细胞毒性具有良好的选择性(SI = 54)且微粒体清除率低。定量构效关系(QSAR)分析表明亲脂性是抗疟活性提高的关键驱动因素。该系列中最具活性的化合物存在亲脂性高、水溶性差和渗透性低的问题。这些结果为指导进一步的化学迭代提供了有用信息。